SEC Tracker
Get the app
EDVA · XBRL financial data

Endovia Health Sciences financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (EDVA's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023†Dec 31, 2024Dec 31, 2025
Revenue2,97611,31618,08718,8504,15573
Cost of revenue2,2528,73412,16913,2813,800—
Gross profit7242,5825,9195,56935517
Total operating expenses18,02531,66527,31320,85516,40214,203
Other operating income (expense)————(1)235
Operating income (loss)(17,301)(29,083)(21,395)(15,287)(16,046)(14,186)
Interest income01632—
Interest expense—4432511,8573,7032,523
Other income (expense)(1,926)(262)(245)(5,717)(7,710)(10,163)
Income tax expense (benefit)000000
Net income (loss)(28,675)(29,051)(21,690)(21,004)(23,757)(25,235)
Earnings per share, basic USD per share(1.06)(1.02)——(17.68)(11.97)
Earnings per share, diluted USD per share(1.06)(1.02)——(17.68)(11.97)
Weighted average shares, basic thousands of shares——37,39042,4501,3382,178
Weighted average shares, diluted thousands of shares18,53828,90037,39042,4501,3382,178
  • † Share count changed about 1/24 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (EDVA's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023†Dec 31, 2024Dec 31, 2025
Cash and cash equivalents3804,1814,43238015281
Accounts receivable4851,1141,81289139716
Inventory7981,9233,7212,25289334
Total current assets2,2448,34210,6583,9771,904632
Property and equipment, net68157049035020513
Right-of-use asset801,03175055635148
Goodwill5,673257257257——
Total assets9,22616,38517,3059,8992,759966
Accounts payable1,5221,9133,3834,4445,2324,810
Total current liabilities5,4166,7794,96614,75019,36916,260
Lease liability, non-current26733481296543
Total liabilities9,3287,5127,98315,50421,39416,267
Accumulated deficit(61,590)(90,641)(112,331)(133,335)(155,832)(181,899)
Total stockholders' equity(9,351)8,8739,322(5,605)(18,635)(15,301)
Total liabilities and equity9,22616,38517,3059,8992,759966
Common shares outstanding (cover page) thousands of shares76,09433,58641,08645,1301,9009,954
  • † Share count changed about 1/24 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (EDVA's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023†Dec 31, 2024Dec 31, 2025
Net income (loss)(28,675)(29,051)(21,690)(21,004)(23,757)(25,235)
Stock-based compensation2,32911,1281,1471,1702,3578,624
Net cash from operating activities(21,317)(14,616)(14,061)(10,189)(8,004)(4,820)
Net cash from investing activities(769)0(103)(14)(3)—
Proceeds from issuing common stock20,18319,63111,4290——
Proceeds from issuing equity—————1,300
Net cash from financing activities22,49518,93414,4476,1487,5455,104
Net change in cash3373,801250(4,052)(365)268
  • † Share count changed about 1/24 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2080 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2080 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Endovia Health Sciences2430*(1,092)*6.4M0.2 quarters 10-QJun 30, 2026
Heritage Distilling Holding Company19736(1,644)*995,9330.0 quarters 10-QJun 30, 2026
SRX Global35,1863,392not reported20.3M— 10-QJun 30, 2026
LQR House145346(1,554)*1.3M4.7 quarters 10-QJun 30, 2026
EQUATOR Beverage01,511not reported9.6M— 10-QSep 30, 2026
Reed's2,4107,488(2,170)*11.9M1.1 quarters 10-QJun 30, 2026
Willamette Valley Vineyards59010,0361,950*5.0M— 10-QJun 30, 2026
Jones Soda2,35110,168(2,007)*125.9M1.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.